MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 116.65
(-1.69%)
EUR 116.65
(-1.69%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 7.95 Billion EUR | -11.57% |
| 2022 | 9 Billion EUR | -2.76% |
| 2021 | 9.25 Billion EUR | -15.32% |
| 2020 | 10.92 Billion EUR | -13.11% |
| 2019 | 12.57 Billion EUR | 89.6% |
| 2018 | 6.63 Billion EUR | -34.45% |
| 2017 | 10.12 Billion EUR | -12.21% |
| 2016 | 11.52 Billion EUR | -9.21% |
| 2015 | 12.69 Billion EUR | 360.29% |
| 2014 | 2.75 Billion EUR | 1.52% |
| 2013 | 2.71 Billion EUR | -23.77% |
| 2012 | 3.56 Billion EUR | 480.07% |
| 2011 | -937.8 Million EUR | 0.63% |
| 2010 | -943.7 Million EUR | -74.31% |
| 2009 | -541.4 Million EUR | 21.84% |
| 2008 | -692.7 Million EUR | -62.38% |
| 2007 | -426.6 Million EUR | 7.28% |
| 2006 | -460.1 Million EUR | 65.19% |
| 2005 | -1.32 Billion EUR | -257.51% |
| 2004 | -369.7 Million EUR | -24.14% |
| 2003 | -297.8 Million EUR | 12.26% |
| 2002 | -339.4 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 8.06 Billion EUR | 4.27% |
| 2024 Q1 | 7.73 Billion EUR | -2.83% |
| 2023 FY | 7.95 Billion EUR | -11.57% |
| 2023 Q4 | 7.95 Billion EUR | -7.36% |
| 2023 Q3 | 8.59 Billion EUR | -8.84% |
| 2023 Q1 | 9.06 Billion EUR | 0.67% |
| 2023 Q2 | 9.42 Billion EUR | 4.02% |
| 2022 Q3 | 9.44 Billion EUR | -7.6% |
| 2022 FY | 9 Billion EUR | -2.76% |
| 2022 Q2 | 10.22 Billion EUR | 10.02% |
| 2022 Q1 | 9.29 Billion EUR | 0.4% |
| 2022 Q4 | 9 Billion EUR | -4.72% |
| 2021 Q2 | 10.17 Billion EUR | 0.63% |
| 2021 Q4 | 9.25 Billion EUR | -1.98% |
| 2021 Q3 | 9.44 Billion EUR | -7.19% |
| 2021 FY | 9.25 Billion EUR | -15.32% |
| 2021 Q1 | 10.11 Billion EUR | -7.49% |
| 2020 Q2 | 12.57 Billion EUR | 2.06% |
| 2020 Q1 | 12.32 Billion EUR | -2.02% |
| 2020 Q3 | 12.11 Billion EUR | -3.7% |
| 2020 Q4 | 10.92 Billion EUR | -9.77% |
| 2020 FY | 10.92 Billion EUR | -13.11% |
| 2019 Q4 | 12.57 Billion EUR | 69.22% |
| 2019 Q1 | 7.15 Billion EUR | 7.78% |
| 2019 Q2 | 7.97 Billion EUR | 11.59% |
| 2019 Q3 | 7.43 Billion EUR | -6.84% |
| 2019 FY | 12.57 Billion EUR | 89.6% |
| 2018 FY | 6.63 Billion EUR | -34.45% |
| 2018 Q1 | 10.04 Billion EUR | -0.72% |
| 2018 Q2 | 10.79 Billion EUR | 7.44% |
| 2018 Q3 | 10.22 Billion EUR | -5.24% |
| 2018 Q4 | 6.63 Billion EUR | -35.14% |
| 2017 Q1 | 11.22 Billion EUR | -2.6% |
| 2017 Q4 | 10.12 Billion EUR | -4.33% |
| 2017 Q3 | 10.57 Billion EUR | -6.71% |
| 2017 Q2 | 11.33 Billion EUR | 0.99% |
| 2017 FY | 10.12 Billion EUR | -12.21% |
| 2016 Q4 | 11.52 Billion EUR | -1.86% |
| 2016 Q3 | 11.74 Billion EUR | -6.87% |
| 2016 Q2 | 12.61 Billion EUR | 3.55% |
| 2016 FY | 11.52 Billion EUR | -9.21% |
| 2016 Q1 | 12.18 Billion EUR | -4.06% |
| 2015 Q2 | 340.9 Million EUR | -82.74% |
| 2015 Q3 | -908.3 Million EUR | -366.44% |
| 2015 Q1 | 1.97 Billion EUR | -28.39% |
| 2015 FY | 12.69 Billion EUR | 360.29% |
| 2015 Q4 | 12.69 Billion EUR | 1497.89% |
| 2014 FY | 2.75 Billion EUR | 1.52% |
| 2014 Q2 | 3.17 Billion EUR | 157.38% |
| 2014 Q1 | 1.23 Billion EUR | -54.58% |
| 2014 Q4 | 2.75 Billion EUR | -2.8% |
| 2014 Q3 | 2.83 Billion EUR | -10.66% |
| 2013 Q1 | 3.65 Billion EUR | 2.53% |
| 2013 FY | 2.71 Billion EUR | -23.77% |
| 2013 Q4 | 2.71 Billion EUR | -7.19% |
| 2013 Q3 | 2.92 Billion EUR | -22.51% |
| 2013 Q2 | 3.77 Billion EUR | 3.38% |
| 2012 Q3 | -1.48 Billion EUR | -41.17% |
| 2012 Q4 | 3.56 Billion EUR | 340.07% |
| 2012 FY | 3.56 Billion EUR | 480.07% |
| 2012 Q1 | -1.08 Billion EUR | -15.89% |
| 2012 Q2 | -1.05 Billion EUR | 3.23% |
| 2011 Q3 | -1.13 Billion EUR | 16.09% |
| 2011 FY | -937.8 Million EUR | 0.63% |
| 2011 Q1 | -1.17 Billion EUR | -24.9% |
| 2011 Q2 | -1.35 Billion EUR | -14.98% |
| 2011 Q4 | -937.8 Million EUR | 17.53% |
| 2010 Q2 | -5.67 Billion EUR | -8.39% |
| 2010 Q1 | -5.23 Billion EUR | -866.51% |
| 2010 FY | -943.7 Million EUR | -74.31% |
| 2010 Q4 | -943.7 Million EUR | 31.99% |
| 2010 Q3 | -1.38 Billion EUR | 75.54% |
| 2009 FY | -541.4 Million EUR | 21.84% |
| 2009 Q4 | -541.4 Million EUR | 0.0% |
| 2008 FY | -692.7 Million EUR | -62.38% |
| 2007 FY | -426.6 Million EUR | 7.28% |
| 2006 FY | -460.1 Million EUR | 65.19% |
| 2005 FY | -1.32 Billion EUR | -257.51% |
| 2004 FY | -369.7 Million EUR | -24.14% |
| 2003 FY | -297.8 Million EUR | 12.26% |
| 2002 FY | -339.4 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| MPH Health Care AG | 8.5 Million EUR | -93507.399% |
| Apontis Pharma AG | -20.8 Million EUR | 38364.423% |
| Dermapharm Holding SE | 921.66 Million EUR | -763.547% |
| Evotec SE | 115.28 Million EUR | -6803.521% |
| PharmaSGP Holding SE | 33.21 Million EUR | -23864.951% |
| SynBiotic SE | 3.59 Million EUR | -221534.835% |